Assessment of Efficacy of AZD2281 in Platinum Sensitive Relapsed Serous Ovarian Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

265

Participants

Timeline

Start Date

August 28, 2008

Primary Completion Date

June 30, 2010

Study Completion Date

October 12, 2023

Conditions
Ovarian Cancer
Interventions
DRUG

AZD2281

Tablets Oral BID

DRUG

matching placebo

matching placebo bid

Trial Locations (107)

1090

Research Site, Vienna

Research Site, Brussels

1130

Research Site, Wein

2031

Research Site, Randwick

3000

Research Site, Melbourne

Research Site, Leuven

3084

Research Site, Heidelberg

3165

Research Site, East Bentleigh

4101

Research Site, South Brisbane

4560

Research Site, Nambour

5000

Research Site, Adelaide

5065

Research Site, Toorak Gardens

6020

Research Site, Innsbruck

10016

Research Site, New York

11619

Research Site, Tallinn

14004

Research Site, Córdoba

14076

Research Site, Caen

18059

Research Site, Rostock

22100

Research Site, Nahariya

24105

Research Site, Kiel

28007

Research Site, Madrid

28041

Research Site, Madrid

30177

Research Site, Hanover

31096

Research Site, Haifa

33027

Research Site, Sunrise

33076

Research Site, Bordeaux

33401

Research Site, West Palm Beach

35043

Research Site, Marburg

37075

Research Site, Göttingen

40217

Research Site, Düsseldorf

43018

Research Site, Lutsk

44202

Research Site, Nantes

45147

Research Site, Essen

46010

Research Site, Valencia

46023

Research Site, Ternopil

46202

Research Site, Indianapolis

51014

Research Site, Tartu

51056

Research Site, Reims

52621

Research Site, Ramat Gan

53105

Research Site, Bonn

58100

Research Site, Holon

61024

Research Site, Kharkiv Region

64239

Research Site, Tel Aviv

65009

Research Site, Odesa

65055

Research Site, Odesa

65199

Research Site, Wiesbaden

69373

Research Site, Lyon

70300

Research Site, Ẕerifin

75004

Research Site, Paris

75020

Research Site, Paris

79106

Research Site, Freiburg im Breisgau

81675

Research Site, München

83092

Research Site, Donetsk

88014

Research Site, Uzhhorod

89081

Research Site, Ulm

90048

Research Site, West Hollywood

91031

Research Site, Jerusalem

91120

Research Site, Jerusalem

94115

Research Site, San Francisco

94704

Research Site, Berkeley

197002

Research Site, Saint Petersburg

197758

Research Site, Saint Petersburg

249036

Research Site, Obninsk

357502

Research Site, Pyatigorsk

394000

Research Site, Voronezh

400015

Research Site, Cluj-Napoca

430222

Research Site, Baia Mare

460021

Research Site, Orenburg

614066

Research Site, Perm

620036

Research Site, Yekaterinburg

656049

Research Site, Barnaul

700106

Research Site, Iași

720237

Research Site, Suceava

02114

Research Site, Boston

02115

Research Site, Boston

02215

Research Site, Boston

02905

Research Site, Providence

V5Z 4E6

Research Site, Vancouver

M5G 2M9

Research Site, Toronto

G1R 2J6

Research Site, Québec

J1H 5N4

Research Site, Sherbrooke

625 00

Research Site, Brno

656 53

Research Site, Brno

775 20

Research Site, Olomouc

100 34

Research Site, Prague

1066 CX

Research Site, Amsterdam

1081 HV

Research Site, Amsterdam

15-027

Research Site, Bialystok

72-003

Research Site, Grzepnica

20 - 081

Research Site, Lublin

60-569

Research Site, Poznan

61-866

Research Site, Poznan

Unknown

Research Site, Poznan

70-111

Research Site, Szczecin

02-781

Research Site, Warsaw

08035

Research Site, Madrid

03022

Research Site, Kyiv

03115

Research Site, Kyiv

DD1 9SY

Research Site, Dundee

EH4 2XR

Research Site, Edinburgh

NW1 2PG

Research Site, London

SW17 0QT

Research Site, London

SW3 6JJ

Research Site, London

M20 4BX

Research Site, Manchester

CH63 4JY

Research Site, Metropolitan Borough of Wirral

HA6 2RN

Research Site, Northwood

SM2 5PT

Research Site, Sutton

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY